In Vitro Diagnostics (IVD) Quality Control Market to Reach $1 Billion by 2022: Analysis By Products and Service, Application, Manufacturer Type, End User & Region
DUBLIN, July 18, 2017 /PRNewswire/ --
The "In Vitro Diagnostics (IVD) Quality Control Market - Global Forecast to 2022" report has been added to Research and Markets' offering.
The global in vitro diagnostics (IVD) quality controls market is estimated to reach USD 1.04 Billion by 2022, growing at a CAGR of 3.5% during the forecast period of 2017 to 2022. This market is mainly driven by the growing number of accredited clinical laboratories across the globe and growing need to ensure the accuracy of the diagnostic test results. However, the increasing use of multi-analyte quality controls is expected to offer lucrative growth opportunities to market players.
In this report, the market is segmented on the basis of product and service, application, manufacturer type, end user, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global IVD quality controls market and its submarkets.
Based on product and service, the market is segmented into quality controls, data management solutions, and quality assurance services. The quality controls segment accounted for the largest share of the market in 2016, and is expected to grow at the fastest CAGR during the forecast period. This can be attributed to the increasing availability & demand for technologically advanced quality control materials with greater stability.
On the basis of application, the In Vitro Diagnostics Quality Controls Market is segmented into the clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation/hemostasis, microbiology, and other applications. The immunochemistry segment accounted for the largest share of the In Vitro Diagnostics Quality Controls Market in 2016. This is mainly due to the increasing number of multi-analyte controls to perform immunoassay tests. The molecular diagnostics segment is expected to grow at highest CAGR during the forecast period, mainly due to the increasing number of molecular diagnostic tests performed in laboratories and need to ensure the accuracy of these complex diagnostic tests.
Companies Mentioned
- Abbott Laboratories Inc.
- Agappe Diagnostics Ltd. (India)
- Audit Microcontrols, Inc. (U.S.)
- Australian Scientific Enterprise Pty. Ltd. (Australia)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Eurocell Diagnostics (France)
- Fortress Diagnostics (U.K.)
- Helena Laboratories
- Ortho Clinical Diagnostics, Inc.
- Pointe Scientific Inc. (U.S.)
- Quantimetrix Corporation (U.S.)
- Randox Laboratories Ltd.
- Roche Diagnostics
- Seracare Life Sciences, Inc.
- Sero As
- Siemens Ag
- Streck Inc. (U.S.)
- Sun Diagnostics, Llc
- Sysmex Corporation
- Technopath Clinical Diagnostics
- Thermo Fisher Scientific, Inc.
- Transasia Bio Medicals Ltd. (India)
- Weqas (U.K.)
- Zeptometrix Corporation (U.S.)
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Global Ivd Quality Controls Market, By Product And Service
8 Global Ivd Quality Controls Market, By Application
9 Global Ivd Quality Controls Market, By Manufacturer Type
10 Global Ivd Quality Controls Market, By End User
11 Global Ivd Quality Control Market, By Region
12 Competitive Landscape
13 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/wsmxgx/in_vitro
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article